Skip to main content

Table 5 Seventeen cases with discordant outcomes between the five-gene assay and pathological diagnosis in the validation cohort. Post-operative diagnoses were used as benchmark reference unless otherwise stated

From: A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions

Sample ID

Five-gene assay

Pathological diagnosis

CB22

FA

Benign PTa

CB116

FA

Benign PT

CB95

FA

Benign PT

CB28

FA

Benign PTa

CB68

FA

Benign PTa

CB120

FA

Borderline PTa

CB130

FA

Borderline PT

CB26

PT

Cellular FA

CB77

PT

FA

CB24

PT

FA

CB29

PT

FA

CB82

PT

FA

CB126

PT

FA

CB144

PT

FAb,c

CB184

PT

FAb,c

CB251

PT

FAb

CB258

PT

FAb,d

  1. FA fibroadenoma, PT phyllodes tumor
  2. aPre-operative pathological diagnoses were inconclusive or discordant with post-operative pathological diagnoses (see Table 6 asterisked cases)
  3. bCases of core biopsies without subsequent surgical excisions. Outcome of the five-gene assay was benchmarked against the pre-operative pathological diagnosis
  4. cFeatures in keeping with fibroadenoma with hyalinized leafy fronds noted albeit without stromal cellularity
  5. dFocal areas of hemorrhage and high cellularity, diagnosis could not be definitively concluded on review